SABBY MANAGEMENT, LLC 13D and 13G filings for Actinium Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-05-01 08:38 am Purchase | 2020-04-22 | 13G | Actinium Pharmaceuticals, Inc. ATNM | SABBY MANAGEMENT, LLC | 669,842 11.000% | 395,889 (+144.51%) | Filing |
| 2020-01-07 6:41 pm Sale | 2019-12-31 | 13G | Actinium Pharmaceuticals, Inc. ATNM | SABBY MANAGEMENT, LLC | 273,953 11.000% | -158,947 (-36.72%) | Filing |